After decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August. Pfizer, the maker of the vaccine, ...
“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...
A vaccine advisory committee for the Food and Drug Administration will review whether to recommend two vaccines for respiratory syncytial virus for approval next week as pharmaceutical giant Pfizer ...
A vaccine designed to protect babies against RSV from birth by immunizing pregnant people has been granted priority review by the Food and Drug Administration, Pfizer announced on Tuesday, potentially ...
The first-of-its-kind vaccine designed to protect infants from RSV, a common respiratory illness that can cause severe breathing problems, could be approved by August. Pfizer, the maker behind the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback